GrantExec

Grants for Special district governments - Health

Explore 2,257 grant opportunities

Delta Health Systems Implementation Program
$400,000
U.S. Department of Health & Human Services (Health Resources and Services Administration)
Federal

Application Deadline

Mar 20, 2025

Date Added

Dec 23, 2024

This funding opportunity provides financial support to rural healthcare organizations in the Delta region to improve service delivery, enhance sustainability, and expand access to care through specific projects.

Health
State governments
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
$1,000,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jul 4, 2024

Date Added

May 10, 2024

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research community. A goal of this Centers program is to support important and innovative research in the muscular dystrophies that is best pursued through an interdisciplinary and collaborative center environment and projects that may not be as effective if supported by "stand-alone" research project grants. The Centers also provide outstanding environments for the training of new scientists electing to pursue careers conducting research in high priority areas of muscular dystrophy. Finally, Center investigators are expected to engage the patient and advocacy communities in conversations to increase awareness of research, encourage patient participation in research, and incorporate the perspectives of these communities in the conduct of patient-centered research.

Health
State governments
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 13, 2024

Date Added

Oct 21, 2021

This Funding Opportunity Announcement (FOA) will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies", or other biospecimens as described in this FOA. Extramural research funded under this FOA may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), blood utilized for "liquid biopsies", tissue swabs, tissue secretions, pleural and esophageal aspirates, feces, or bodily fluids like sweat, urine, CSF, breast milk and saliva. Investigator-designed experiments will explore how different biospecimen preanalytical conditions affect emerging and clinically relevant biomarkers quantified by a variety of testing platforms. The results from this research program will improve the understanding of how analytical quantification of clinically relevant biomarkers is affected by variation in biospecimen collection, processing, and storage procedures. The overall goal is to expedite biomarker clinical assay development through evidence-based standardization of biopsy handling practices.

Education
State governments
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)
$275,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 16, 2024

Date Added

Nov 3, 2021

The "Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer" grant aims to fund preliminary research into how the human microbiome affects the body's immune response to cancer, with a focus on how specific microbes or their byproducts can either increase or prevent tumor formation, and how the amount, timing, and duration of beneficial microbes can impact their effectiveness.

Education
State governments
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed)
$400,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jun 27, 2025

Date Added

Oct 3, 2022

This funding opportunity provides financial support for educational programs that train new researchers in Down syndrome to improve understanding and treatment of co-occurring health conditions throughout the lifespan.

Education
State governments
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
$475,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 7, 2024

Date Added

Jul 20, 2023

This grant provides funding for researchers at U.S. institutions to explore innovative uses of nanotechnology in cancer research, focusing on improving targeted delivery and diagnostic capabilities for specific cancer types.

Education
State governments
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 26, 2024

Date Added

Aug 9, 2023

This funding opportunity supports research institutions and organizations in developing and testing new treatments and recovery methods for individuals with alcohol use disorder, particularly focusing on underserved populations and innovative approaches.

Health
State governments
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
$150,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 1, 2024

Date Added

Nov 28, 2023

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage current NCI R01 research projects to incorporate new technologies from the NCI Innovative Molecular Analysis Technologies program, with the goal of enhancing their original research and speeding up scientific discoveries in cancer research.

Education
State governments
Providing targeted technical assistance to the HIV/TB prevention-care-treatment continuum using cost efficient and scalable quality improvement approaches to address program gaps in support of sustainable HIV services in Zambia under PEPFAR
$15,000,000
U.S. Department of Health & Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Feb 24, 2025

Date Added

Jul 26, 2024

This funding opportunity provides financial support to organizations working in Zambia to improve HIV and TB prevention, care, and treatment services through innovative and sustainable quality improvement strategies.

Health
State governments
Artificial Intelligence and Technology Collaboratory Coordinating Center (U24 Clinical Trial Not Allowed)
$1,900,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 9, 2025

Date Added

Jun 10, 2025

This funding opportunity supports U.S.-based organizations in developing a centralized hub to advance the use of artificial intelligence and technology in research related to aging and Alzheimer's Disease, fostering collaboration and stakeholder engagement across multiple projects.

Health
State governments
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 30, 2024

Date Added

Mar 23, 2023

The overall goal of this UG3/UH3 Exploratory/Developmental phased initiative is to support the discovery and development of novel natural products that are safe, nontoxic, and efficacious for cancer interception and prevention. 1. Purpose of UG3: Select clinically relevant targets and develop and validate assays for bioactivity as well as toxicity screening 2. Purpose of UH3 phase: Screening libraries, structure elucidation, full-scale characterization, efficacy testing, and development of the screened agents.

Education
State governments
Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 17, 2024

Date Added

Nov 9, 2021

This grant provides access to specialized resources and expertise for researchers developing gene-based therapies for extremely rare neurological disorders, helping them prepare for regulatory submissions and advance their therapeutic projects.

Health
State governments
Ryan White HIV/AIDS Program Part C Capacity Development Program
$150,000
U.S. Department of Health & Human Services (Health Resources and Services Administration)
Federal

Application Deadline

Mar 18, 2025

Date Added

Jun 12, 2024

This funding opportunity provides financial support to healthcare organizations serving low-income and underserved populations living with HIV, enabling them to improve their capacity to deliver high-quality HIV primary health care services.

Health
State governments
FY2024 U.S. Consulate General Osaka-Kobe: 2025 US-ROK-Japan Trilateral Global Leadership Youth Summit
$200,000
U.S. Department of State (U.S. Mission to Japan)
Federal

Application Deadline

Aug 24, 2024

Date Added

Jul 26, 2024

Funding Opportunity Title: FY2024 U.S. Consulate General Osaka-Kobe: 2025 US-ROK-Japan Trilateral Global Leadership Youth Summit Funding Opportunity Number: OSAKA-PAS-FY24-04 Deadline for Applications: August 24, 2024 (by 11:59 pm JST) Assistance Listing Number: 19.040 Public Diplomacy Programs Total Amount Available: $200,000 A. PROGRAM DESCRIPTION The U.S. Consulate General Osaka-Kobe, in partnership with the U.S. Embassy Tokyo Public Affairs Section and the U.S. Embassy Seoul Public Diplomacy Section of the U.S. Department of State, announces an open competition for organizations to submit applications to carry out the 2025 Young Trilateral Leaders (YTL) networks United States-Republic of Korea-Japan Trilateral Global Leadership Youth Summit, to be held in the Summer of 2025 in the Kansai region of Japan (potential host cities include Osaka, Kobe, and Kyoto, among others). In the face of growing security, trade, financial, and environmental instability in the Indo-Pacific region, the trilateral relationship between the United States, Japan, and the Republic of Korea has never been more important. This program will build upon the inaugural 2024 Trilateral Global Leadership Youth Summit held in Busan, Republic of Korea. This series of programs aims to build the expertise in strategic issues of youth from the United States and their peers from two of our closest allies and to provide them with a platform through which to regularly meet and engage on global issues. Priority Region(s): Japan, Republic of Korea Program Objectives: The Summit will focus on developing the leadership skills and global outlook of a cohort of approximately 50 youth leaders. Participants should have demonstrated leadership abilities, a track record of engagement in their communities, and the capacity to collaborate with peers from other nations. We will also leverage the expertise of youth leaders from similar USG-sponsored youth leadership initiatives such as the Young Southeast Asian Leaders Initiative (YSEALI) and the Young Pacific Leaders (YPL) Program to ensure young people in East Asia understand broader regional issues and how youth have successfully worked together in other areas of the Indo-Pacific. This Youth Summit is a key pillar of the Young Trilateral Leaders (YTL) network, a regional youth initiative that creates space for young leaders to make meaningful contributions to trilateral policy discussions. YTL fosters a tight-knit network of young leaders who understand the issues facing the trilateral partnership while working together to identify innovative solutions to future global challenges. Participants who complete the program can continue contributing to the network as YTL alumni. The 2025 Kansai Summit will build upon the outputs of the 2024 Busan Summit. Additional trilateral youth activities may be sustained via small grants administered by U.S. Consulate General Osaka-Kobe and U.S. Embassies Tokyo and Seoul. Participants and Audiences: The recipient and the U.S. Consulate General Osaka-Kobe, in partnership with the U.S. Embassy Tokyo and the U.S. Embassy Seoul, will be jointly responsible for recruitment, vetting, and selection of program participants. The U.S. government retains final approval authority for all participants, who will apply via a standardized application form on a public website with program information and associated information and social media campaigns. Participants should be between the ages of 18 and 35 years old, have English proficiency, and be able to demonstrate a history of excellence in local and regional youth leadership activities. Applicants from regions and constituencies who are underrepresented in official programs are strongly encouraged to apply. Program Structure: Proposals should incorporate four primary elements (1) Pre-program promotion and selection process: The recipient will design and implement a program promotion and online application process for prospective participants, including a dedicated program website. Proposals should include a plan to incorporate U.S. Consulate/U.S. Embassy promotional channels, U.S. Consulate/U.S. Embassy concurrence on the selection process, and U.S. Consulate/U.S. Embassy participation in applicant selection itself. (2) Four-week period (minimum) of virtual engagement: The recipient will organize a series of preparatory virtual engagements with the participants to generate excitement for the summit, prepare summit objectives and structure, and allow participants to build rapport. These events should also include subject-matter experts (academic, civil society, government, etc.) from all three countries who can speak about the trilateral relationship, youth civic engagement, and other issues relevant to the theme of global youth leadership. These engagements should also lay out logistics and expectations for the in-person summit. (3) Three-day (minimum) summit in the Kansai region of Japan: The recipient will organize a summit to include lectures, exercises, facilitated workshops, and training sessions that cover topics such as organizing, advocacy, civic engagement, and briefings on international issues (on topics such as climate change, regional security, trade, science and technology, and other relevant themes). The sessions should be led by expert trainers and subject-matter experts representing the United States, Japan, and the Republic of Korea. Participants may also lead sessions about youth initiatives in their own countries. The final output of this summit should be an actionable implementation plan leading to follow-on activities for program alumni and, potentially, future Summit participants. The recipient may also organize limited visits to relevant cultural and/or political sites and community service/social engagement activities to connect with the host community. The recipient will be responsible for arranging all logistics, including travel, transportation, food, and other items as necessary. Decisions on venues for the Summit will be determined with the U.S. Consulate/U.S. Embassy. (4) Follow-on activities: Following the summit, the recipient will conduct mentorship activities and facilitate/monitor any potential follow-on projects. *Please find attached the full notice

Community Development
County governments
Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
$9,500,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jul 2, 2024

Date Added

Feb 22, 2024

This Notice of Funding Opportunity (NOFO) invites applications for a U54 Specialized Center (henceforth: Consortium) to provide resources, expertise, and coordination to advance innovative, high-quality research on palliative care for those with serious illness across the lifespan. This research infrastructure will encompass Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD), cancer, and other serious illnesses and populations relevant to the partnering Institutes, Centers, and Offices (ICOs). NIH currently funds many palliative care research projects across the ICOs, and there is a need for a structure to leverage synergies, coordinate efforts, develop the scientific workforce, and address remaining gaps in the field. The goals of this initiative include generating new scientific knowledge, in part through supporting pilot and exploratory studies; fostering development of early- and mid-career palliative care investigators; serving as a national platform to provide research resources and facilitate high-quality palliative care research; engaging healthcare systems and community-based organizations as research partners and settings for palliative care research; and disseminating research findings, best practices, data, and other impactful resources to the palliative care research and clinical communities. An important focus of the Consortiums work will be on facilitating research to understand and address disparities in access, quality, and use of palliative care services for health disparities populations or in underserved areas.

Education
State governments
Distance Learning and Telemedicine Grants
$1,000,000
U.S. Department of Agriculture (Rural Utilities Service)
Federal

Application Deadline

Mar 6, 2025

Date Added

Jan 7, 2025

This funding opportunity provides financial support to various organizations for improving healthcare and education services in rural areas through advanced telecommunications technology, with a focus on addressing substance use disorders and enhancing access to specialized resources.

Business and Commerce
State governments
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
$150,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 1, 2024

Date Added

Nov 28, 2023

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage existing NCI P50 specialized centers to enhance their current cancer research by integrating new technologies or methods developed by the NCI Innovative Molecular Analysis Technologies program.

Education
State governments
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
$300,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 20, 2025

Date Added

Dec 18, 2024

This funding opportunity provides financial support for research projects that implement effective treatments for opioid and stimulant use disorders, focusing on improving care systems and addressing health disparities.

Education
State governments
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 17, 2024

Date Added

Mar 18, 2022

This grant provides funding for researchers to conduct preclinical studies on the effects of radionuclide-based cancer therapies, aiming to improve treatment strategies and outcomes for cancer patients.

Education
State governments
Clinical Trial Readiness to Understand and Develop Solutions to Social, Ethical, Behavioral Implications and Barriers to Health Equity in ADRD (R01 - Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 4, 2024

Date Added

Jun 12, 2024

The "Clinical Trial Readiness to Understand and Develop Solutions to Social, Ethical, Behavioral Implications and Barriers to Health Equity in ADRD" grant aims to fund research that prepares for clinical trials focused on understanding and addressing the social, ethical, and behavioral barriers that prevent equal health outcomes for Alzheimer's Disease and Related Dementias (ADRD) in underserved and marginalized communities.

Health
State governments